Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patients

Journal of the Neurological Sciences

Volumn 305, Issue 1-2, 2011, Pages 45-52

  Kiiski, H ^a   Reilly, R B ^a   Lonergan, R ^b   Kelly, S ^b   O'Brien, M ^c   Kinsella, K ^b   Bramham, J ^c   Burke, T ^c   O'Donnchadha, S ^c   Nolan, H ^a   Hutchinson, M ^b   Tubridy, N ^b   Whelan, R ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Auditory event related potentials; Cognition; Longitudinal; Multiple sclerosis; Neuropsychology; Visual event related potentials

Indexed keywords

ADULT; ARTICLE; AUDITORY STIMULATION; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; EXPANDED DISABILITY STATUS SCALE; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; VISUAL STIMULATION;

ADULT; COGNITION DISORDERS; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS;

EID: 79955688459     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2011.03.018     Document Type: Article

References (43)

1. Hoffmann S, Tittgemeyer M, von Cramon DY. Cognitive impairment in multiple sclerosis. Curr Opin Neurol 2007 Jun;20(3):275-80. (Pubitemid 46743108)
2. Rogers JM, Panegyres PK. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. J Clin Neurosci 2007 Oct;14(10):919-27. (Pubitemid 47333187)
3. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple-sclerosis. 2. Impact on employment and social functioning. Neurology 1991 May;41(5):692-6.
4. Kalmar JH, Halper J, Gaudino EA, Moore NB, DeLuca J. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis. Neuropsychology 2008 Jul;22(4):442-9. (Pubitemid 351992891)
5. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a reviewof cross-sectional and longitudinal studies. JNeurol Sci 2006 Jun 15;245(1-2):41-6. (Pubitemid 43775956)
6. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999 May;122(Pt 5):871-82.
7. Barker-Collo SL. Within session practice effects on the PASAT in clients with multiple sclerosis. Arch Clin Neuropsych 2005 Mar;20(2):145-52. (Pubitemid 40222151)
8. Leocani L, Locatelli T, Martinelli V, Rovaris M, Falautano M, Filippi M, et al. Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings. J Neurol Neurosurg Psychiatry 2000 Aug;69(2):192-8. (Pubitemid 30466023)
9. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007 Oct;118(10):2128-48. (Pubitemid 47385341)
10. Kok A. On the utility of P3 amplitude as a measure of processing capacity. Psychophysiology. 2001 14 March 2003;38(3):557-77. (Pubitemid 32422300)
11. Whelan R, Lonergan R, Kiiski H, Nolan H, Kinsella K, Bramham J, et al. A high-density ERP study reveals latency, amplitude, and topographical differences in multiple sclerosis patients versus controls. Clin Neurophysiol 2010 Sep;121(9):1420-6.
12. Kiiski H, Whelan R, Lonergan R, Nolan H, Kinsella K, Hutchinson M, et al. Preliminary evidence for correlation between PASAT performance and P3a and P3b amplitudes in progressive multiple sclerosis. Eur J Neurol 2010 [Short communication]; doi: 10.1111/j.1468-1331.2010.03172.x.
13. Aminoff JC, Goodin DS. Long-latency cerebral event-related potentials in multiple sclerosis. J Clin Neurophysiol 2001 Jul;18(4):372-7. (Pubitemid 33104913)
14. Ellger T, Bethke F, Frese A, Luettmann RJ, Buchheister A, Ringelstein EB, et al. Event-related potentials in different subtypes of multiple sclerosis - a cross-sectional study. J Neurol Sci 2002 Dec 15;205(1):35-40. (Pubitemid 36158990)
15. Gil R, Zai L, Neau JP, Jonveaux T, Agbo C, Rosolacci T, et al. Event-related auditory evoked potentials and multiple sclerosis. Electroencephalogr Clin Neurophysiol 1993 May - Jun;88(3):182-7.
16. Piras MR, Magnano I, Canu ED, Paulus KS, Satta WM, Soddu A, et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 2003 Jul;74(7):878-85. (Pubitemid 36782987)
17. Polich J, Romine JS, Sipe JC, Aung M, Dalessio DJ. P300 in multiple sclerosis: a preliminary report. Int J Psychophysiol 1992 Mar;12(2):155-63.
18. Sailer M, Heinze HJ, Tendolkar I, Decker U, Kreye O, v Rolbicki U, et al. Influence of cerebral lesion volume and lesion distribution on event-related brain potentials in multiple sclerosis. J Neurol 2001 Dec;248(12):1049-55. (Pubitemid 34134540)
19. Gerschlager W, Beisteiner R, Deecke L, Dirnberger G, Endl W, Kollegger H, et al. Electrophysiological, neuropsychological and clinical findings in multiple sclerosis patients receiving interferon beta-1b: a 1-year follow-up. Eur Neurol 2000;44(4):205-9.
20. Jung J, Morlet D, Mercier B, Confavreux C, Fischer C. Mismatch negativity (MMN) in multiple sclerosis: an event-related potentials study in 46 patients. Clin Neurophysiol 2006 Jan;117(1):85-93.
21. Whelan R, Lonergan R, Kiiski H, Nolan H, Kinsella K, Hutchinson M, et al. Impaired information processing speed and attention allocation in multiple sclerosis patients versus controls: a high-density EEG study. J Neurol Sci 2010 Jun 15;293(1-2):45-50.
22. Leocani L, Comi G. Neurophysiological markers. Neurol Sci 2008 Sep;29:S218-21.
23. Pelayo R, Montalban X, Minoves T, Moncho D, Rio J, Nos C, et al. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? Mult Scler 2010 Jan;16(1):55-61.
24. Flechter S, Vardi J, Finkelstein Y, Pollak L. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study. Isr Med Assoc J 2007 Jun;9(6):457-9. (Pubitemid 46979149)
25. Pliskin NH, Hamer DP, Goldstein DS, Towle VL, Reder AT, Noronha A, et al. Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology 1996 Dec;47(6):1463-8. (Pubitemid 26422537)
26. Pokryszko-Dragan A, Zagrajek M, Slotwinski K, Gruszka E, Bilinska M, Podemski R. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis - a pilot study. Clin Neurol Neurosur 2009 Jul;111(6):503-6.
27. Polich J. Clinical application of the P300 event-related brain potential. Phys Med Rehabil Clin N Am 2004 Feb;15(1):133-61. (Pubitemid 38210037)
28. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005 Dec;58(6):840-6.
29. Tombaugh TN. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 2006 Jan;21(1):53-76. (Pubitemid 41802927)
30. Kurtzke JF. Historical and clinical perspectives of the expanded disability status scale. Neuroepidemiology 2008;31(1):1-9. (Pubitemid 351957392)
31. Vieweg BW, Hedlund JL. The Hamilton rating scale for depression. J Oper Psychiatry 1979;10(2):149-65.
32. Oostenveld R, Praamstra P. The five percent electrode system for high-resolution EEG and ERP measurements. Clin Neurophysiol 2001 Apr;112(4):713-9. (Pubitemid 32245646)
33. Whelan R. Effective analysis of reaction time data. Psychol Rec 2008;58(3):475-82.
34. Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Meth 2004 Mar 15;134(1):9-21. (Pubitemid 38224183)
35. Delorme A, Sejnowski T, Makeig S. Enhanced detection of artifacts in EEG data using higher-order statistics and independent component analysis. Neuroimage 2007 Feb 15;34(4):1443-9. (Pubitemid 46187079)
36. Comerchero MD, Polich J. P3a, perceptual distinctiveness, and stimulus modality. Cogn Brain Res 1998 Jul;7(1):41-8. (Pubitemid 28419437)
37. Polich J. Task-difficulty, probability, and inter-stimulus interval as determinants of P300 from auditory-stimuli. Electroen Clin Neuro 1987 Jul;68(4):311-20. (Pubitemid 17082606)
38. Williams J, O'Rourke K, Hutchinson M, Tubridy N. The face-symbol test and the symbol-digit test are not reliable surrogates for the Paced Auditory Serial Addition Test in multiple sclerosis. Mult Scler 2006 Oct;12(5):599-604. (Pubitemid 46940634)
39. De Sonneville LM, Boringa JB, Reuling IE, Lazeron RH, Ader HJ, Polman CH. Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia 2002;40(11):1751-65. (Pubitemid 34626423)
40. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003;16(3):283-8 [review].
41. Whitwell JL. Longitudinal imaging: change and causality. Curr Opin Neurol 2008 Aug;21(4):410-6.
42. Lazeron RHC, Boringa JB, Schouten M, Uitdehaag BMJ, Bergers E, Lindeboom J, et al. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler 2005 Oct;11(5):524-31. (Pubitemid 41387696)
43. Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple sclerosis - natural history, pathophysiology and management. CNS Drugs 2002;16(7):445-55. (Pubitemid 34729149)